Stay updated on TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.

Latest updates to the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision v3.3.4 was added and Revision v3.3.3 was removed. This is a minor, non-content-changing update to the page’s versioning.SummaryDifference0.1%

- Check13 days agoChange DetectedNew Publications entry added for the Nat Med 2026 paper by Musher et al. under Publications; this update does not affect core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a Locations section with Texas as a site and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a new revision label (v3.3.2) and the previous label (v3.2.0) is removed. No study details or functions are altered.SummaryDifference0.1%

- Check64 days agoChange DetectedA government funding status notice banner was removed from the page, and this change does not affect the study details or enrollment processes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded detailed outcome definitions for progression-free survival and overall survival, and updated key study dates (completion date 2025-07-31; last update posted estimated 2025-10-02/2025-10-29). Removed the prior generic 'To evaluate...' statements related to these outcomes.SummaryDifference1.0%

Stay in the know with updates to TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.